Abstract
Staphylococcus aureus and Escherichia hermanii in diabetes patient.
Highlights
We report the first case of double invasive infection by E. hermanii and Staphylococcus aureus and emphasize the importance of screening of all the septic foci for demonstrating a polymicrobial invasive infection
In August 2000, a 54-year-old comatose man was admitted to our infectious diseases department with a 10-day history of fever
A bacterial invasive infection was considered and the antibiotic therapy was started with ceftriaxone, 2 g/day, and rifampin, 1,200 mg/day
Summary
Public health dispatch: update: fatal and severe liver injuries associated with rifampin and pyrazinamide treatment for latent tuberculosis infection. Framework for evaluating public health surveillance systems for early detection of outbreaks; recommendations from the CDC working group. Escherichia hermanii is an extremely rare etiologic agent for invasive infections; only four cases were published from 1980 to 2002. We report the first case of double invasive infection by E. hermanii and Staphylococcus aureus and emphasize the importance of screening of all the septic foci for demonstrating a polymicrobial invasive infection.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
